Amgen’s Lumakras Falls Short Of Mirati’s Adagrasib In Pancreatic Cancer

Pressure On To Make Most Of Lung Cancer Foothold

 
• By Ayisha Sharma
  
medically accurate illustration of cancer cell
Just 1% Of Pancreatic Tumors Have A KRAS Mutation. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas